| Literature DB >> 33085708 |
Roi Charles Pineda1, Ralf Th Krampe2, Yves Vanlandewijck1, Debbie Van Biesen1.
Abstract
The high prevalence of postural instability in individuals with intellectual disability (ID) warrants the need for reliable and practical postural control assessments. Stabilometry is a postural control assessment that has been widely used for clinical populations. However, the scant systematic knowledge about the reliability of stabilometric protocols for adults with ID renders results questionable and limits its value for clinicians and researchers. The study's purpose was to develop a stabilometric protocol for adults with and without ID based on optimal combinations of shortest necessary trial durations and the least number of trial repetitions that guarantee sufficient reliability. Participants performed six trials of bipedal standing in 2 vision (eyes open vs eyes closed) x 2 surface (solid vs compliant) conditions on a force platform. Several parameters were calculated from the first 10-, 20-, and 30-s interval of every center-of-pressure (COP) trial data. For different trial durations, we identified the number of trials that yielded acceptable relative (intraclass correlation coefficient ≥ 0.70) and absolute (standard error of measurement < 20%) reliability using the Spearman-Brown prophecy formula. To determine the optimal combination of trial duration and number of repetition for each COP parameter, we implemented a two-step process: 1) identify the largest number of repetition for each of the three trial durations and then 2) select the trial duration with the lowest number of repetition. For both ID- and non-ID groups, we observed a trend whereby shorter trial durations required more repetitions and vice versa. The phase plane and ellipse area were the most and least reliable center-of-pressure parameter, respectively. To achieve acceptable reliability, four 30-s trials of each experimental condition appeared to be optimal for testing participants with and without ID alike. The results of this research can inform stabilometric test protocols of future postural control studies of adults with ID.Entities:
Mesh:
Year: 2020 PMID: 33085708 PMCID: PMC7577434 DOI: 10.1371/journal.pone.0240702
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Participant characteristics.
| Characteristics¤ | ID group ( | Non-ID group ( |
|---|---|---|
| 29.20 (7.92)¤ | 29.00 (7.62)¤ | |
| Sex (female / male)¤ | 1 / 4¤ | 1 / 4¤ |
| 26.50 (1.38)¤ | 26.44 (1.40)¤ | |
| 75.80 (10.0)¤ | 115.60 (7.9)¤ | |
| 25.98 (4.3)¤ | 22.25 (2.1)¤ | |
| 2.90 (2.1)¤ | 3.05 (1.1)¤ |
Figures enclosed in parentheses are standard deviations; ID, intellectual disability; IQ, intelligence quotient; BMI, body mass index; PA, physical activity
Number of trials (k) that would yield an ICC2,k ≥ 0.70 and SEM% ≤ 20 and corresponding ICC2,k and SEM% for trial lengths of 10, 20, and 30 s.
| Participants with intellectual disability¤ | Participants without intellectual disability¤ | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Center of pressure parameters¤ | 10-s trial¤ | 20-s trial¤ | 30-s trial¤ | 10-s trial¤ | 20-s trial¤ | 30-s trial¤ | ||||||||||||
| ICC¤ | SEM¤ | ICC¤ | SEM¤ | ICC¤ | SEM¤ | ICC¤ | SEM¤ | ICC¤ | SEM¤ | ICC¤ | SEM¤ | |||||||
| ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | |
| 3¤ | 0.83¤ | 19.9¤ | 3¤ | 0.86¤ | 18.7¤ | 3¤ | 0.91¤ | 19.2¤ | 9¤ | 0.86¤ | 19.5¤ | 4¤ | 0.83¤ | 19.4¤ | 6¤ | 0.82¤ | 19.4¤ | |
| 13¤ | 0.90¤ | 19.4¤ | 12¤ | 0.90¤ | 19.9¤ | 6¤ | 0.90¤ | 18.8¤ | 3¤ | 0.77¤ | 19.7¤ | 2¤ | 0.81¤ | 16.2¤ | 3¤ | 0.82¤ | 17.3¤ | |
| 6¤ | 0.71¤ | 19.4¤ | 4¤ | 0.75¤ | 16.4¤ | 3¤ | 0.75¤ | 15.2¤ | 15¤ | 0.81¤ | 19.5¤ | 4¤ | 0.74¤ | 16.8¤ | 3¤ | 0.76¤ | 17.7¤ | |
| 4¤ | 0.73¤ | 14.7¤ | 3¤ | 0.75¤ | 12.7¤ | 4¤ | 0.75¤ | 15.3¤ | 1¤ | 0.76¤ | 17.6¤ | 1¤ | 0.77¤ | 16.1¤ | 1¤ | 0.80¤ | 14.8¤ | |
| ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | |
| 14¤ | 0.71¤ | 16.6¤ | 5¤ | 0.72¤ | 14.9¤ | 3¤ | 0.70¤ | 16.2¤ | 16¤ | 0.86¤ | 19.5¤ | 5¤ | 0.83¤ | 18.9¤ | 4¤ | 0.80¤ | 19.0¤ | |
| —¤ | —¤ | —¤ | 15¤ | 0.70¤ | 16.5¤ | 12¤ | 0.72¤ | 14.4¤ | —¤ | —¤ | —¤ | —¤ | —¤ | —¤ | —¤ | —¤ | —¤ | |
| 2¤ | 0.75¤ | 16.2¤ | 2¤ | 0.75¤ | 16.2¤ | 1¤ | 0.76¤ | 14.9¤ | 20¤ | 0.84¤ | 19.9¤ | 9¤ | 0.72¤ | 19.2¤ | 5¤ | 0.74¤ | 19.7¤ | |
| 5¤ | 0.71¤ | 17.3¤ | 2¤ | 0.74¤ | 16.2¤ | 2¤ | 0.78¤ | 14.7¤ | 3¤ | 0.73¤ | 18.0¤ | 2¤ | 0.80¤ | 13.7¤ | 3¤ | 0.75¤ | 14.7¤ | |
| ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | |
| 2¤ | 0.80¤ | 16.1¤ | 2¤ | 0.79¤ | 15.2¤ | 2¤ | 0.80¤ | 12.9¤ | 2¤ | 0.72¤ | 16.9¤ | 2¤ | 0.82¤ | 13.0¤ | 1¤ | 0.72¤ | 14.1¤ | |
| 28¤ | 0.89¤ | 19.8¤ | 7¤ | 0.85¤ | 19.7¤ | 3¤ | 0.83¤ | 18.5¤ | 3¤ | 0.77¤ | 14.4¤ | 2¤ | 0.70¤ | 13.9¤ | 2¤ | 0.77¤ | 11.7¤ | |
| 32¤ | 0.70¤ | 18.4¤ | 4¤ | 0.71¤ | 12.2¤ | 3¤ | 0.72¤ | 9.8¤ | 4¤ | 0.74¤ | 16.9¤ | 3¤ | 0.76¤ | 16.5¤ | 2¤ | 0.72¤ | 16.5¤ | |
| 7¤ | 0.73¤ | 13.7¤ | 2¤ | 0.73¤ | 10.3¤ | 4¤ | 0.71¤ | 13.1¤ | 2¤ | 0.71¤ | 19.6¤ | 2¤ | 0.79¤ | 16.3¤ | 1¤ | 0.78¤ | 15.6¤ | |
| ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | |
| 2¤ | 0.82¤ | 11.6¤ | 2¤ | 0.82¤ | 10.9¤ | 1¤ | 0.79¤ | 12.2¤ | 1¤ | 0.83¤ | 14.4¤ | 1¤ | 0.80¤ | 14.6¤ | 1¤ | 0.82¤ | 13.2¤ | |
| 7¤ | 0.81¤ | 19.3¤ | 3¤ | 0.79¤ | 18.1¤ | 2¤ | 0.84¤ | 15.9¤ | 6¤ | 0.73¤ | 17.1¤ | 2¤ | 0.78¤ | 14.7¤ | 1¤ | 0.73¤ | 14.9¤ | |
| 2¤ | 0.73¤ | 13.2¤ | 3¤ | 0.76¤ | 12.0¤ | 2¤ | 0.71¤ | 13.4¤ | 3¤ | 0.77¤ | 16.1¤ | 1¤ | 0.70¤ | 17.4¤ | 1¤ | 0.74¤ | 15.0¤ | |
| 3¤ | 0.76¤ | 11.3¤ | 1¤ | 0.74¤ | 10.3¤ | 1¤ | 0.78¤ | 9.7¤ | 2¤ | 0.75¤ | 16.0¤ | 2¤ | 0.79¤ | 14.7¤ | 1¤ | 0.75¤ | 15.1¤ | |
| Ellipse area¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ |
| 8¤ | 0.89¤ | 19.0¤ | 10¤ | 0.94¤ | 19.2¤ | 5¤ | 0.93¤ | 19.8¤ | 25¤ | 0.94¤ | 19.8¤ | 11¤ | 0.94¤ | 19.1¤ | 12¤ | 0.93¤ | 19.4¤ | |
| 216¤ | 0.98¤ | 19.9¤ | 59¤ | 0.97¤ | 19.8¤ | 15¤ | 0.95¤ | 19.7¤ | 219¤ | 0.89¤ | 19.9¤ | 3¤ | 0.83¤ | 18.7¤ | 5¤ | 0.82¤ | 19.9¤ | |
| 10¤ | 0.94¤ | 19.1¤ | 3¤ | 0.90¤ | 18.2¤ | 3¤ | 0.89¤ | 18.7¤ | 35¤ | 0.94¤ | 19.9¤ | 4¤ | 0.82¤ | 18.2¤ | 2¤ | 0.91¤ | 15.0¤ | |
| 38¤ | 0.88¤ | 19.8¤ | 3¤ | 0.80¤ | 19.1¤ | 12¤ | 0.89¤ | 19.7¤ | 5¤ | 0.88¤ | 18.5¤ | 3¤ | 0.88¤ | 17.2¤ | 2¤ | 0.85¤ | 18.6¤ | |
| Phase plane¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ |
| 3¤ | 0.75¤ | 15.6¤ | 2¤ | 0.76¤ | 13.3¤ | 1¤ | 0.75¤ | 14.2¤ | 1¤ | 0.79¤ | 12.5¤ | 1¤ | 0.81¤ | 11.9¤ | 1¤ | 0.79¤ | 11.4¤ | |
| 9¤ | 0.86¤ | 19.2¤ | 4¤ | 0.80¤ | 18.9¤ | 2¤ | 0.79¤ | 18.4¤ | 4¤ | 0.72¤ | 14.1¤ | 2¤ | 0.75¤ | 11.9¤ | 2¤ | 0.73¤ | 11.0¤ | |
| 3¤ | 0.75¤ | 15.1¤ | 2¤ | 0.77¤ | 11.8¤ | 2¤ | 0.78¤ | 12.0¤ | 4¤ | 0.71¤ | 16.3¤ | 3¤ | 0.77¤ | 12.7¤ | 2¤ | 0.74¤ | 12.7¤ | |
| 4¤ | 0.73¤ | 11.8¤ | 2¤ | 0.72¤ | 10.8¤ | 2¤ | 0.81¤ | 11.1¤ | 3¤ | 0.79¤ | 14.9¤ | 2¤ | 0.77¤ | 13.0¤ | 1¤ | 0.73¤ | 12.4¤ | |
*k, ICC2, and SEM% cannot be calculated when ICC2,1 ≤ 0; ML, mediolateral; AP, anteroposterior; EO-S, eyes open, solid surface; EC-S, eyes closed, solid surface; EO-F, eyes open, foam surface; EC-F, eyes closed, foam surface
Means and standard deviations of center of pressure parameters of participants with and without intellectual disability (ID), as well as values for t-statistic, significance (p), and effect size (Hedge’s g).
| with ID¤ | without ID¤ | ||||||
|---|---|---|---|---|---|---|---|
| Hedge’s | |||||||
| ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | |
| 4.6¤ | 1.2¤ | 4.8¤ | 1.2¤ | -0.29¤ | 0.78¤ | 0.17¤ | |
| 5.5¤ | 2.1¤ | 5.0¤ | 1.1¤ | 0.40¤ | 0.70¤ | 0.23¤ | |
| 9.9¤ | 1.4¤ | 9.5¤ | 2.4¤ | 0.30¤ | 0.77¤ | 0.16¤ | |
| 16.1¤ | 2.8¤ | 15.3¤ | 4.9¤ | 0.30¤ | 0.77¤ | 0.17¤ | |
| ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | |
| 8.6¤ | 2.3¤ | 7.3¤ | 2.3¤ | 0.96¤ | 0.37¤ | 0.55¤ | |
| 11.7¤ | 4.3¤ | 8.8¤ | 2.3¤ | 1.3¤ | 0.22¤ | 0.76¤ | |
| 16.8¤ | 3.4¤ | 14.8¤ | 4.1¤ | 0.85¤ | 0.42¤ | 0.49¤ | |
| 27.7¤ | 5.5¤ | 22.4¤ | 6.5¤ | 1.4¤ | 0.21¤ | 0.78¤ | |
| Phase plane (unitless)¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ | ¤ |
| 10.3¤ | 2.8¤ | 8.5¤ | 2.0¤ | 1.1¤ | 0.30¤ | 0.64¤ | |
| 13.4¤ | 4.8¤ | 9.8¤ | 1.8¤ | 1.6¤ | 0.15¤ | 0.90¤ | |
| 20.8¤ | 4.7¤ | 18.9¤ | 4.0¤ | 0.69¤ | 0.51¤ | 0.40¤ | |
| 32.8¤ | 7.6¤ | 26.9¤ | 6.1¤ | 1.4¤ | 0.21¤ | 0.77¤ | |
ML = mediolateral; AP = anteroposterior; EO-S = eyes open, solid surface; EC-S = eyes closed, solid surface; EO-F = eyes open, foam surface; EC-F = eyes closed, foam surface